hGHR-106

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamehGHR-106

Drug Alias NamehGHR-106

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionGonadotropin-releasing hormone inhibitorsAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsT lymphocytes stimulants

TargetsGonadotropin-releasing hormone

Therapy Area/IndicationsInfertility, FemaleNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesProtheragen Inc

China Registration ClassN/A

Active CompaniesProtheragen Inc

Inactive CompaniesN/A

Active IndicationsInfertility, FemaleNeoplasms

Inactive IndicationsN/A

ATC CodeN/A